Babraham Institute launches new website
Today we’ve unveiled our new website offering dynamic and responsive ways to explore the Institute’s research, staff, opportunities and activities.
Babraham scientists reveal how environmental signals can reprogramme stem cells
Epigenetics researchers at the Babraham Institute have identified the biological process that leads to global loss of the genome’s methylation memory when cells are reprogrammed at fertilisation to the so-called ‘ground-state’ development.
Babraham establishes cancer-focused Knowledge Exchange collaboration with AstraZeneca
The Babraham Institute is one of three world-leading biomedical research institutions in Cambridge that has entered into a strategic alliance with AstraZeneca, to advance cancer research and develop and evaluate new therapeutic strategies to tackle prostate and pancreatic cancers.
The Babraham Institute announces the formation of Babraham Commercialisation Services Ltd
The Babraham Institute has announced the formation of a new wholly-owned trading arm, Babraham Commercialisation Services Ltd (BCS), to support its Knowledge Exchange and Commercialisation (KEC) activities.
Babraham scientist elected to the Fellowship of the Royal Society
Dr Phill Hawkins, a Group Leader in Signalling at the Babraham Institute, has today been elected to the Fellowship of the Royal Society. A leading authority on biochemical signalling pathways, Dr Hawkins studies how cells respond to signals and communicate with each other to ensure the healthy development of an individual.
Babraham scientists discover how a minute molecule mediates immunological memory
Babraham scientists, collaborating with research groups in the USA, have discovered how a minute molecule called MicroRNA-155 mediates the immune response of certain types of white blood cells (CD8+ T cells) and also helps to establish immunological memory against pathogens like the influenza virus.
Babraham scientists collaborate in EU research initiative to tackle neurodegenerative disease
The Babraham Institute has joined forces with a consortium of leading European academic laboratories and industrial scientists from small and medium enterprises (SMEs), to study human brain ageing and age-related diseases. The four year project – AgedBrainSYSBIO on the systems biology of synapse proteins & ageing – has received €6M from the European Commission under the 7th Framework’s Health…
Babraham scientists help in effort to produce maps of human metabolism in health and disease
Babraham scientists, collaborating with an international consortium of researchers from 35 institutions across the world, have produced an instruction manual for the human genome that will provide unparalleled insights into the relationship between an individual’s genetic make-up and their lifestyle. The paper, published online this week in Nature Biotechnology, provides the best model yet to…
New research facility opens at the Babraham Institute
The Babraham Institute opened a new research building yesterday (Weds), uniting all of the Institute’s academic research groups under one roof to investigate a range of research questions, including the challenges of healthy ageing.
The Babraham Institute announces collaboration with Karus Therapeutics to explore PI3 Kinase
The Babraham Institute and Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, today announced that they have entered into a collaboration to further characterise novel treatments for inflammatory diseases, through the regulation of phosphatidylinositol-3-kinases (PI3K) - a family of enzymes important to immune cell…
International collaboration with Babraham researchers reveals how cell membranes reassemble
An international collaboration between researchers at the Babraham Institute, Cancer Research UK’s London Research Institute, Imperial College London and Amherst College in the US, reveal for the first time that a lipid called diacylglyercol (DAG) is instrumental in ensuring that the nuclear membrane reforms correctly after cell division and therefore plays a key role maintaining the delicate…
Babraham researchers reveal how heart muscle cells get remodelled
Researchers at the Babraham Institute have discovered how signalling processes within the heart, controlled by a minute molecule known as miR133a, can trigger the development of enlarged heart cells, a process called hypertrophy. Hypertrophy often leads to cardiac failure, which accounts for 25% deaths in the UK and is a primary cause of death in the elderly.
Babraham Institute research provides insight into DNA reprogramming
Babraham Institute scientists have gained a new understanding of when and how the DNA in developing egg and sperm cells is 'reset', in preparation for making a new embryo. Decoding this reprogramming has major implications for our understanding of development.
Ageing Research summit at Babraham explores basic biology underpinning healthier lifespan
Understanding ageing is a new research priority worldwide and two hundred scientists from around the world recently gathered at the Babraham Institute for a summit on Ageing Research, which attracted leading researchers from the USA, Europe, Israel and the UK.
Where science meets policy: students organise Cambridge Biological & Life Sciences Symposium
Four PhD students from the Babraham Institute organised the University of Cambridge’s annual symposium for Biological and Life Sciences students (SymBLS) at Peterhouse in September, bringing together students and their research with academics, industry and policymakers. The government and industry attendees particularly enjoyed connecting, and in some cases reconnecting, with cutting edge…
The Babraham Institute is pleased to announce: ‘A Question of Ageing’
The Babraham Institute’s next public engagement event tackles an issue that affects us all, the science of healthy ageing. Following an international conference on Ageing Research at Babraham next month, there will be an event for the public at the Guildhall on Saturday 22nd September that will enable people to engage with researchers to consider the scientific and clinical challenges as well as…
Babraham research reveals how tumours acquire resistance and identify a new target
Scientists at the Babraham Institute, working with collaborators at AstraZeneca, have made a breakthrough in understanding how a particular signalling pathway can promote aberrant cell growth and pinpointed a mutation that enables tumours to circumvent certain treatments.
Babraham-US collaboration reveals how injured nerves initiate self-destruction
Scientists at the Babraham Institute, together with collaborators in the USA, have made a breakthrough in understanding how axons self-destruct in injury, ageing and disease. Axons are the long slender ‘wires’ projecting from nerve cells that communicate messages around the body.
Babraham research provides new insight into placental growth and healthy pregnancy
Scientists at the Babraham Institute have gained a new understanding of how the growth of the placenta is regulated before birth, which has important implications for a healthy pregnancy.
Minister opens new facilities to boost bioscience business at Babraham
Minister of State for Universities and Science, David Willets, who opened new bioscience facilities for business start-ups at the Babraham Research Campus, also highlighted funding - including £37m allocated to the Babraham Institute - which aims to ensure that the UK's bioscience research base remains globally competitive.
University of Cambridge and Babraham Institute unveil new epigenetics research technique
Collaboration between scientists at Cambridge University and the Babraham Institute have demonstrated a new technique that will significantly improve scientists’ ability to perform epigenetics research and help unlock the door to understanding how cells develop and function. The research, published in the journal 'Science' has important implications for stem cell research and the development of…